Liver stiffness in young people with glycogen storage disease type III
Part of Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at liver stiffness (a sign of scarring, called fibrosis) in children and young adults with type III glycogen storage disease. Researchers want to see how common liver fibrosis is in this group and how it changes over time, using a non-invasive ultrasound-like test called elastography.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 21 years old (minor or young adult)
- You have been diagnosed with type III glycogen storage disease (GSD III)
- You have had at least one liver elastography test (a special ultrasound that checks liver stiffness) during your regular checkups
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This study uses a special ultrasound technique called elastography to measure how stiff the liver is in children with cholestatic liver disease. The goal is to see how well this test can detect liver scarring (fibrosis) compared to a liver biopsy.
This trial tests if a special ultrasound (elastography) can help measure liver damage in people with liver failure. It may find problems like confusion, bleeding, fluid buildup, or liver cancer earlier.
This study uses an ultrasound probe during a routine endoscopy to measure liver stiffness, which can help detect liver scarring (fibrosis) in people with fatty liver disease (MASLD). If you are already scheduled for an endoscopy and have no signs of advanced liver scarring, you may be able to join.
This study tests a new, non-invasive way to measure liver stiffness using a device called FibroScan. It aims to make liver checkups easier and more comfortable for people with liver disease.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.